MEDIPOST Co. Ltd

MEDIPOST Co., Ltd. provides stem cell therapeutic solutions for unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank, and offers cord blood banking services for incurable diseases. The company markets CARTISTEM for cartilage degeneration, including degenerative osteoarthritis, and is developing stem cell drugs such as PNEUMOSTEM for bronchopulmonary dysplasia and NEUROSTEM for Alzheimer's disease. It also develops SMUP-IA-01 for osteoarthritis and SMUP-IV-01 for diabetic nephropathy, and offers nutritional supplements under the MOVITA brand. Founded in 2000, MEDIPOST is headquartered in Seongnam, South Korea.